Recombinant Legionella pneumophila Elongation factor Ts (tsf)

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Recombinant Legionella pneumophila Elongation Factor Ts (tsf) is a genetically engineered version of the elongation factor Ts protein produced by Legionella pneumophila, the causative agent of Legionnaires’ disease. EF-Ts is a critical component of the bacterial translation machinery, facilitating the regeneration of elongation factor Tu (EF-Tu) by catalyzing the exchange of GDP for GTP. This process ensures efficient delivery of aminoacyl-tRNA to the ribosome during protein synthesis.

In L. pneumophila, EF-Ts is encoded by the tsf gene (lpg1713) and plays a role in bacterial adaptation to environmental stressors, such as nutrient limitation and temperature shifts, which are critical for survival in water systems and host cells .

Table 1: Key Features of L. pneumophila EF-Ts

PropertyDetail
Gene locuslpg1713 (tsf)
Protein length~300 amino acids (predicted)
FunctionRegeneration of EF-Tu for translation elongation
Expression regulationDownregulated during water exposure (-1.40-fold at 2 hours)
Role in virulenceLinked to stringent response and metabolic adaptation

Recombinant Production and Applications

Recombinant EF-Ts is typically produced in E. coli expression systems. While specific protocols for L. pneumophila EF-Ts are not detailed in the literature, standard methods include:

  • Cloning: The tsf gene is inserted into expression vectors under inducible promoters (e.g., T7 or lac).

  • Purification: Affinity chromatography (e.g., His-tag systems) followed by gel filtration for homogeneity .

Research applications:

  • Study of translation mechanisms in L. pneumophila.

  • Investigation of stress response pathways (e.g., RpoS-mediated survival in water) .

  • Target for antimicrobial drug development due to its essential role in protein synthesis.

Role in Virulence and Environmental Survival

EF-Ts is indirectly implicated in L. pneumophila virulence through its interaction with global regulatory systems:

  • Stringent response: EF-Ts expression is modulated by the alarmone (p)ppGpp, which coordinates metabolic shutdown during nutrient stress .

  • Transcriptomic downregulation: Exposure to water triggers a 1.4-fold reduction in tsf expression, aligning with a broader transcriptomic shift toward quiescence and stress resistance .

  • Host infection: While EF-Ts itself is not a secreted effector, its activity supports bacterial proliferation by maintaining translation during intracellular replication .

Key Research Findings

  1. Environmental adaptation:

    • tsf is downregulated during L. pneumophila’s transition to water, reducing metabolic activity to conserve energy .

    • This aligns with LetA/S two-component system activity, which represses metabolic genes under stress .

  2. Link to antibiotic resistance:

    • L. pneumophila in water exhibits increased antibiotic tolerance, potentially due to EF-Ts-mediated translational efficiency adjustments .

  3. Interactions with host machinery:

    • While L. pneumophila effectors like Lgt1-3 target eukaryotic elongation factors (e.g., eEF1A) , EF-Ts remains a bacterial-specific factor critical for pathogen survival .

Future Directions and Challenges

  • Structural studies: High-resolution crystallography of L. pneumophila EF-Ts to identify species-specific drug targets.

  • Functional genomics: CRISPR-based knockout studies to validate tsf’s role in virulence and stress adaptation.

  • Therapeutic potential: Screening for EF-Ts inhibitors to disrupt bacterial translation without affecting human homologs.

References

  1. LetA/S system regulation of tsf .

  2. Transcriptomic changes during water exposure .

  3. Role in stringent response .

  4. Homologous recombination dynamics in L. pneumophila .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format unless you specify a format preference when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tsf; LPC_1142Elongation factor Ts; EF-Ts
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-292
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Legionella pneumophila (strain Corby)
Target Names
tsf
Target Protein Sequence
MSTISAALVM QLRERTGAGM MECKKFLIAT NGDIEQAIIE MRKAGQAKAD KKADRVAAEG IIVIARSSDE RTAVMLEINS ETDFVARDEN FTNFANAVAD VALTSLPKNI EDLSNQALSS GATVEQARQE LVAKIGENIK LRRLEKMHCD GVIGYYLHGS RIGVMVALKN GSEALAKDIA MHVAASKPMV VSRDQVPAEA IENEREIFTA QAKESGKPQE IIDKMIDGRI NKFIDEVSLL GQPYVKDPNI KVGQLLKEKN AEVISFVRYE VGEGIEKKED NFVEEVMAQV RT
Uniprot No.

Target Background

Function
Associates with the EF-Tu.GDP complex and promotes GDP to GTP exchange. Remains bound to the aminoacyl-tRNA.EF-Tu.GTP complex until GTP hydrolysis on the ribosome.
Database Links

KEGG: lpc:LPC_1142

Protein Families
EF-Ts family
Subcellular Location
Cytoplasm.

Q&A

What is Legionella pneumophila Elongation factor Ts (tsf) and what role does it play in bacterial translation?

Elongation factor Ts (tsf) is a critical protein involved in bacterial protein synthesis. In L. pneumophila, this factor functions as a guanine nucleotide exchange factor that catalyzes the regeneration of active EF-Tu- GTP from inactive EF-Tu- GDP during the elongation phase of translation. The protein plays an essential role in bacterial survival by ensuring efficient protein synthesis. L. pneumophila, as an intracellular bacterial pathogen, requires robust protein synthesis machinery to cause Legionnaires' Disease, an inflammatory pneumonia . The tsf gene encodes this protein, and its proper functioning is crucial for bacterial viability and pathogenicity.

What expression systems are most effective for producing recombinant L. pneumophila EF-Ts?

For laboratory-scale production of recombinant L. pneumophila EF-Ts, E. coli-based expression systems typically yield the best results. The BL21(DE3) strain with pET-based vectors containing the L. pneumophila tsf gene allows for IPTG-inducible expression. When designing expression constructs, researchers should consider the following optimization parameters:

Expression ParameterRecommended ConditionNotes
Expression temperature18-25°CLower temperatures reduce inclusion body formation
Induction OD6000.6-0.8Mid-log phase yields optimal expression
IPTG concentration0.1-0.5 mMLower concentrations often improve solubility
Expression time16-18 hoursExtended expression at lower temperatures
Affinity tagN-terminal 6xHisMinimal interference with protein function

For studies requiring native protein function, tag removal using specific proteases (TEV or PreScission) is recommended after initial purification steps.

How can researchers optimize purification protocols for obtaining structurally intact recombinant L. pneumophila EF-Ts?

Purification of recombinant L. pneumophila EF-Ts requires careful optimization to maintain structural integrity and functionality. A multi-step purification approach is recommended:

  • Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-based resins with His-tagged protein.

  • Intermediate purification: Ion exchange chromatography (typically Q-Sepharose) to remove contaminants with different charge properties.

  • Polishing step: Size exclusion chromatography to obtain monodisperse protein preparations.

Buffer optimization is crucial for maintaining stability during purification:

Buffer ComponentRecommended RangePurpose
HEPES or Tris20-50 mM, pH 7.5-8.0Maintains physiological pH
NaCl100-300 mMPrevents non-specific interactions
Glycerol5-10%Stabilizes protein structure
DTT or TCEP1-5 mMPrevents oxidation of cysteine residues
EDTA0.5-1 mMChelates metal ions that may promote degradation

After purification, validation of functional activity through nucleotide exchange assays is essential to confirm that the recombinant protein retains its native activity.

What role might L. pneumophila EF-Ts play in bacterial virulence and host-pathogen interactions?

L. pneumophila EF-Ts likely contributes to virulence indirectly by supporting the bacterial protein synthesis required for pathogenesis. As L. pneumophila requires a functional Dot/Icm type IV secretion system to cause disease , efficient translation of virulence factors is critical. Research suggests several potential connections between translation factors and virulence:

  • During intracellular replication, L. pneumophila must adapt to host defenses while maintaining protein synthesis.

  • Translation machinery components may be targeted by host defense mechanisms to restrict bacterial growth.

  • Some bacterial pathogens utilize translation factors as "moonlighting proteins" with secondary functions in virulence.

Experimental approaches to investigate these connections include:

  • Creating conditional tsf mutants to examine effects on virulence factor production

  • Assessing the impact of EF-Ts depletion on intracellular survival using culture-independent quantification methods

  • Examining potential interactions between EF-Ts and host cellular components

How do post-translational modifications affect L. pneumophila EF-Ts function in different environmental conditions?

Post-translational modifications (PTMs) of L. pneumophila EF-Ts may serve as regulatory mechanisms adapting translation efficiency to changing environments. Common PTMs to investigate include:

  • Phosphorylation: May regulate nucleotide exchange activity in response to nutrient availability

  • Methylation: Potentially affects protein-protein interactions with EF-Tu

  • Acetylation: Could influence protein stability or subcellular localization

Research approaches for studying PTMs include:

  • Mass spectrometry-based proteomics to identify modification sites

  • Site-directed mutagenesis to create PTM-mimetic variants

  • Comparative analysis of PTM patterns between virulent and avirulent strains

  • Assessment of modification changes during different growth phases or infection stages

What are effective protocols for assessing the nucleotide exchange activity of recombinant L. pneumophila EF-Ts?

Several complementary approaches can be used to measure the nucleotide exchange activity of recombinant L. pneumophila EF-Ts:

Fluorescence-based assays:
Using fluorescently labeled GDP analogs (such as mant-GDP) allows real-time monitoring of nucleotide exchange. When mant-GDP is bound to EF-Tu, fluorescence increases; displacement during nucleotide exchange causes a measurable decrease in signal.

Radioactive nucleotide exchange assays:
Traditional approaches using [³H]GDP or [³⁵S]GTPγS provide quantitative measurement of exchange rates.

Stopped-flow kinetics:
For detailed mechanistic studies, stopped-flow measurements with fluorescence detection enable analysis of fast reaction kinetics.

A typical reaction setup includes:

ComponentConcentrationNotes
EF-Tu- GDP0.5-1 μMPre-formed complex
EF-Ts0.1-2 μMVaries for kinetic analysis
GTP50-100 μMExcess to drive reaction forward
Buffer-Typically 50 mM Tris pH 7.5, 100 mM KCl, 10 mM MgCl₂
Temperature25-37°CPhysiologically relevant range

Controls should include reactions lacking EF-Ts to determine background exchange rates and heat-inactivated EF-Ts to confirm that activity is protein-specific.

How can researchers design experiments to investigate the role of EF-Ts in L. pneumophila protein synthesis during infection?

Investigating the role of EF-Ts during infection requires approaches that bridge in vitro biochemistry with infection models:

  • Conditional expression systems:

    • Develop tetracycline-regulated or similar inducible systems to control tsf expression

    • Monitor effects on global protein synthesis using techniques like puromycin incorporation

  • Cell infection models:

    • Use culture-independent quantification methods like IMS-FCM (Immunomagnetic Separation-Flow Cytometry) to assess bacterial viability and replication under EF-Ts modulation

    • Compare growth kinetics of wildtype and tsf-modulated strains in relevant host cells

  • Ribosome profiling:

    • Apply ribosome profiling to identify translational changes when EF-Ts function is altered

    • Focus on effects on virulence factor translation specifically

  • Protein synthesis reporters:

    • Engineer L. pneumophila strains expressing fluorescent protein reporters under different promoters

    • Monitor translation efficiency of various gene classes during infection

When designing these experiments, researchers should consider the complex host-pathogen interactions, as L. pneumophila is known to induce unique transcriptional responses in host cells through effector proteins .

What approaches can be used to study potential moonlighting functions of L. pneumophila EF-Ts?

Beyond its canonical role in translation, EF-Ts may possess moonlighting functions that contribute to L. pneumophila pathogenesis:

  • Protein-protein interaction screening:

    • Use pull-down assays with tagged recombinant EF-Ts followed by mass spectrometry

    • Employ bacterial two-hybrid systems to screen for interacting partners

    • Consider yeast two-hybrid screening against host protein libraries to identify potential host targets

  • Subcellular localization studies:

    • Use immunogold electron microscopy to determine precise localization

    • Create fluorescent protein fusions to monitor dynamics during infection

    • Perform cell fractionation followed by western blotting

  • Ectopic expression in host cells:

    • Express L. pneumophila EF-Ts in host cells to identify potential effects on host functions

    • Monitor changes in host translation, signaling pathways, or immune responses

  • Structural biology approaches:

    • Identify potential binding pockets or surfaces distinct from the EF-Tu interaction site

    • Screen for potential small molecule binding using thermal shift assays

What are common challenges in obtaining functionally active recombinant L. pneumophila EF-Ts and how can they be addressed?

Researchers frequently encounter several challenges when working with recombinant L. pneumophila EF-Ts:

ChallengeSolution Approaches
Poor solubility- Lower induction temperature (16-18°C)
- Use solubility-enhancing tags (MBP, SUMO)
- Optimize buffer conditions with additives like arginine or trehalose
Aggregation during purification- Include low concentrations of non-ionic detergents (0.05% Tween-20)
- Add 5-10% glycerol to all buffers
- Perform purification at 4°C
Loss of activity- Minimize freeze-thaw cycles
- Add stabilizing agents like glycerol or sucrose
- Store protein in small aliquots with reducing agents
Proteolytic degradation- Add protease inhibitor cocktails during lysis
- Include EDTA in buffers where compatible
- Minimize processing time
Inconsistent activity- Standardize expression and purification protocols
- Validate each batch with activity assays
- Use internal controls across experiments

Using the appropriate culture-independent quantification methods for activity assessment, such as those developed for L. pneumophila monitoring, can help ensure consistency across preparations .

How can researchers interpret and reconcile contradictory results in L. pneumophila EF-Ts studies?

When faced with contradictory results, researchers should consider:

  • Strain variations:

    • Different L. pneumophila strains may exhibit variation in EF-Ts sequence and regulation

    • Compare results using the same reference strain (Philadelphia-1 is commonly used)

  • Experimental conditions:

    • Differences in buffer compositions can significantly affect activity measurements

    • Temperature, pH, and ionic strength should be carefully controlled and reported

  • Protein preparation methods:

    • Tag position and removal can affect protein function

    • Storage conditions and freeze-thaw cycles may impact activity

  • Assay sensitivity and specificity:

    • Different assay methods have varying sensitivities and potential artifacts

    • Cross-validate findings using complementary techniques

  • Biological context:

    • In vitro results may differ from in vivo observations due to the complex intracellular environment

    • Consider the effects of host cell factors on L. pneumophila processes

To reconcile contradictory findings, researchers should perform systematic comparisons under standardized conditions and consider collaborative studies to validate results across laboratories.

What are promising approaches for targeting L. pneumophila EF-Ts for antimicrobial development?

As an essential component of bacterial translation, EF-Ts represents a potential target for antimicrobial development. Several approaches show promise:

  • Structure-based drug design:

    • Focus on the EF-Ts/EF-Tu interface as a specific target

    • Use computational methods to identify small molecules that disrupt protein-protein interactions

    • Develop high-throughput screening assays based on fluorescence polarization or FRET

  • Allosteric inhibitors:

    • Target unique structural features of L. pneumophila EF-Ts

    • Identify compounds that lock EF-Ts in inactive conformations

    • Screen for molecules that prevent nucleotide exchange function

  • Peptide-based inhibitors:

    • Design peptides mimicking key interaction regions between EF-Ts and EF-Tu

    • Develop cell-penetrating peptide conjugates to improve delivery

    • Use phage display to identify novel peptide binders

  • RNA-based approaches:

    • Develop antisense oligonucleotides targeting tsf mRNA

    • Explore CRISPR-Cas systems for specific targeting of the tsf gene

    • Consider RNA aptamers that bind specifically to L. pneumophila EF-Ts

Such approaches might provide alternatives to conventional antibiotics for treating Legionnaires' Disease, which remains a significant health concern.

How might systems biology approaches advance our understanding of L. pneumophila EF-Ts function?

Systems biology offers powerful frameworks for understanding EF-Ts within the broader context of L. pneumophila pathogenesis:

  • Multi-omics integration:

    • Combine transcriptomics, proteomics, and metabolomics to map the impact of EF-Ts modulation

    • Correlate changes in translation efficiency with metabolic adaptations during infection

    • Build predictive models of translation factor networks

  • Protein interaction networks:

    • Map the complete interactome of L. pneumophila EF-Ts

    • Identify condition-specific interactions that emerge during different infection stages

    • Compare interactomes across different bacterial pathogens

  • Computational modeling:

    • Develop kinetic models of L. pneumophila translation

    • Simulate the effects of EF-Ts alterations on global protein synthesis

    • Create models that integrate translation with other cellular processes

  • Single-cell approaches:

    • Apply single-cell RNA-seq to understand heterogeneity in translation during infection

    • Use microfluidics to track translation dynamics in individual bacteria during host interaction

    • Correlate translation efficiency with bacterial fate within host cells

These approaches can help identify critical nodes in translation networks that might serve as intervention points for future therapeutic development.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.